Overview
Understanding Alnylam Pharmaceuticals integration
Who this is for: Wholesalers, distributors, group purchasing organizations and logistics partners that buy from Alnylam Pharmaceuticals, and the suppliers and service providers that support it.
Scope: This guide describes typical practice for this kind of trading relationship; Alnylam Pharmaceuticals's own program details are confirmed during onboarding.
Alnylam Pharmaceuticals is a biopharmaceutical company developing RNA interference therapeutics. ECOM's directory lists it under biotechnology. Companies that sell to or supply pharmaceutical and biotechnology firms usually deal with wholesalers and distributors on the sales side, and with material, packaging and logistics suppliers on the supply side, under regulatory expectations for lot, expiry and traceability.
With a pharmaceutical or biotechnology company, lot, contract and product identifiers have to match across orders, shipments and invoices, or documents are rejected. Alnylam Pharmaceuticals' own EDI or API specification is not part of this guide and no Alnylam Pharmaceuticals document was read: treat what follows as typical practice for a pharmaceutical or biotechnology company, and confirm the documents, X12 version, delivery method and testing steps with Alnylam Pharmaceuticals.
ECOM maps the documents to your ERP and distribution systems, tests them with the trading partner, monitors every file after go-live and handles partner changes, as software, as a managed service or both.